Approximately 7 million people in the U.S., suffer from mitral regurgitation in the U.S., and they represent almost 2% of the nation's population. Similarly, approximately the same number of people suffer from the condition in Europe. This group includes 4.1 million people who have moderate to severe mitral regurgitation. The number of new patients suffering with mitral regurgitation disease added each year is 250,000. Among this 4.1 million patients, only about 20% or 1.67 million are eligible for the treatment. This creates huge opportunity for the global transcatheter mitral valve replacement market.
http://www.prnewswire.com/news-rele...-trends-and-forecast-2014-2022-300435461.html
- Forums
- ASX - By Stock
- AVR
- Ann: Exclusive Supply Agreement with 4C Medical
Ann: Exclusive Supply Agreement with 4C Medical, page-3
-
- There are more pages in this discussion • 95 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
|
|||||
Last
$18.31 |
Change
0.000(0.00%) |
Mkt cap ! $351.9M |
Open | High | Low | Value | Volume |
$18.30 | $19.00 | $18.00 | $363.4K | 19.82K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 500 | $18.13 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$18.50 | 1000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 500 | 18.130 |
1 | 300 | 18.110 |
1 | 50 | 18.080 |
1 | 200 | 18.050 |
1 | 1000 | 18.000 |
Price($) | Vol. | No. |
---|---|---|
18.500 | 1000 | 1 |
19.000 | 438 | 1 |
19.290 | 325 | 1 |
19.800 | 264 | 1 |
19.870 | 202 | 1 |
Last trade - 15.59pm 01/07/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO
Charles Armstrong
CEO
SPONSORED BY The Market Online